TickerFactsScreenerDevelopers

ORAMED PHARMACEUTICALS INC. (ORMP) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2011: $2.2K2012: $2.0K2013: $6.0K2014: $14.0K2015: $1.0K2016: $9.0K2017: $7.0K2018: $5.0K2019: $15.0K2020: $82.0K2021: $375.0K2022: $496.0K2023: $254.0K2024: $18.0K2025: $9.0K$9.0K
2011Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$9.0K-50.0%
2024$18.0K-92.9%
2023$254.0K-48.8%
2022$496.0K+32.3%
2021$375.0K+357.3%
2020$82.0K+446.7%
2019$15.0K+200.0%
2018$5.0K-28.6%
2017$7.0K-22.2%
2016$9.0K+800.0%
2015$1.0K-92.9%
2014$14.0K+133.3%
2013$6.0K+200.0%
2012$2.0K-8.3%
2011$2.2K—